Teva Pharmaceutical Industries other operating income or expenses for the twelve months ending June 30, 2024 were $-0.522B, a 39.86% decline year-over-year.
Teva Pharmaceutical Industries annual other operating income or expenses for 2023 were $-0.994B, a 49.67% decline from 2022.
Teva Pharmaceutical Industries annual other operating income or expenses for 2022 were $-1.975B, a 219.06% increase from 2021.
Teva Pharmaceutical Industries annual other operating income or expenses for 2021 were $-0.619B, a 2995% increase from 2020.
Teva Pharmaceutical Industries Other Operating Income or Expenses 2010-2024 | TEVA